They aren't Bioambers components. And Bioamber was liquidated and retained no employees. So you think LCY is gearing up to pay them for Reverdia's components? How much they paying? Who would send the invoice? Will the amounts they receive go to the secured creditors? Why weren't those future proceeds included in the payouts to creditors before the Monitor was discharged?
News 
Market Data 
Discover 
